ACT BIOTECH INC — Form D
ACT BIOTECH INC of SAN FRANCISCO, CA, a company, filed a Form D exempt-offering notice with the SEC on 2010-05-03. The offering totals $2.0M, of which $1.0M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2010-05-03
- Form: D
- Accession: 0001434913-10-000001
- Industry: Biotechnology
- Exemptions: 06
- Total offering: $2.0M
- Amount sold: $1.0M
- Remaining: $1.0M
- Investors: 1
- Date of first sale: 2010-04-27
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-141410
Issuer
- Name: ACT BIOTECH INC
- CIK: 0001434913
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2008
- Address: 717 MARKET STREET, SUITE 650, SAN FRANCISCO, CA, 94103
- Phone: (415) 230-3901
Officers, directors & promoters (8)
| Name | Role | Location |
|---|
| John Mahoney | Executive Officer | Boulder, CO |
| Georg Nebgen | Director | New York, NY |
| Wolf-Dieter Busse | Director | San Francisco, CA |
| Wolf-Dieter Busse | Executive Officer | San Francisco, CA |
| Ali Fattaey | Executive Officer | San Francisco, CA |
| John Costantino | Director | New York, NY |
| Nils C Behnke | Director | San Francisco, CA |
| Gary Lazar | Director | Cupertino, CA |
Other filings by this issuer (2)
More